NEW YORK (GenomeWeb News) – Proteome Sciences will supply its tandem mass tag — or TMT — technology to German drug discovery company Cellzome, Proteome Sciences announced today.
 
Cellzome was an early beta test site for Proteome Sciences’ TMTsixplex, which allows up to six samples to be labeled, mixed, and subsequently identified. Now, Cellzome plans to apply the TMTsixplex technology to its own proteomics platform approach for analyzing protein-drug and protein-protein interactions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.